Company Filing History:
Years Active: 2006-2010
Title: Innovations of Stein Sæbøe-Larsen in Cancer Treatment
Introduction
Stein Sæbøe-Larsen is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of cancer treatment through his innovative work on antigenic peptides derived from telomerase. With a total of 2 patents, his inventions focus on eliciting T cell mediated immunity to combat cancer.
Latest Patents
Stein's latest patents revolve around proteins and peptides that stimulate T cell responses. His inventions include compositions for cancer vaccines and methods for generating T lymphocytes capable of recognizing and destroying tumor cells in mammals. More specifically, his work provides a telomerase protein or peptide for use in cancer treatment or prophylaxis. The preferred embodiment of his method involves generating a T cell response against telomerase, which is crucial for effective cancer therapy.
Career Highlights
Stein Sæbøe-Larsen is associated with Gemvax AS, where he continues to develop his groundbreaking ideas. His work is pivotal in advancing cancer treatment methodologies and enhancing the efficacy of immunotherapies.
Collaborations
Stein collaborates with talented individuals such as Jon Amund Eriksen and Mona Møller, contributing to a dynamic research environment that fosters innovation.
Conclusion
Stein Sæbøe-Larsen's contributions to cancer treatment through his innovative patents highlight the importance of research in developing effective therapies. His work exemplifies the potential of immunotherapy in combating cancer and improving patient outcomes.